katie8288Jun 23, 20220 min readuniQure Announces Update on Low-Dose Cohort in Phase I/II Clinical Trial of AMT-130 Gene Therapy
21 with Juvenile Huntington's disease: An adult, not a Child; feeling stuck in a unique and difficult place.
